We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Microparticles Coated with Apoptotic Antigens Blunt Autoimmune Attack

By LabMedica International staff writers
Posted on 29 Nov 2012
The molecular processes responsible for autoimmune diseases such as multiple sclerosis (MS) can be shut down by exposing cells in the immune system to microparticles coated with antigens from cells that have been reduced to fragments by apoptosis.


Investigators at Northwestern University (Chicago, IL, USA) had previously shown that antigen-bound apoptotic cells could be injected safely into patients with MS. More...
While this treatment induced T cell tolerance that prevented further autoimmune attack and slowed progression of the disease, it was not practical for routine clinical use. Senior author Dr. Stephen Miller, professor of immunology at Northwestern University, explained, "Cellular therapy is extremely expensive as it needs to be carried out in a large medical center that has the capability to isolate patient's white blood cells under sterile conditions and to re-infuse those antigen-coupled cells back into the patients. It is a costly, difficult, and time-consuming procedure."

A search for alternative methods to replace living cells as transporters of apoptotic antigens led to the development of suitable synthetic microparticles. In a paper published in the November 18, 2012, online edition of the journal Nature Biotechnology the investigators described the preparation of polystyrene or biodegradable poly(lactide-co-glycolide) microparticles coated with antigens relevant to a mouse model of MS (relapsing experimental autoimmune encephalomyelitis).

Mice with relapsing experimental autoimmune encephalomyelitis were treated by intravenous infusion of the microparticles. Results showed that treatment with the microparticles prevented the onset and modified the course of the disease. These beneficial effects required microparticle uptake by marginal zone macrophages expressing the scavenger receptor MARCO and were mediated in part by the activity of regulatory T cells, abortive T-cell activation, and T-cell anergy.

The biodegradable poly(lactide-co-glycolide) used to formulate the microparticles has already been approved by the [US] Food and Drug Administration and is currently used in sutures as well as in clinical trials to deliver anticancer agents. Dr. Miller said, "I think we have come up with a very potent way to induce tolerance that can be easily translated into clinical practice. We are doing everything we can now to take this forward."

Related Links:

Northwestern University




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
HPV Test
Allplex HPV28 Detection
New
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: 123RF

Screening After Pneumococcal Disease May Reveal Undiagnosed Blood Cancer or Immune Disorders

Severe pneumococcal disease requiring hospitalization often presents as pneumonia, particularly in older adults and people with cancer or compromised immune function. Because M protein testing and antibody... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.